iData Insights

Quest PharmaTech Inc. - Product Pipeline Review – 2015 Now Available at iData Insights

News   •   Dec 01, 2015 10:09 IST

provides an overview of the Quest PharmaTech Inc. s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Quest PharmaTech Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Quest PharmaTech Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Quest PharmaTech Inc.s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Quest PharmaTech Inc.s pipeline products Reasons to buy - Evaluate Quest PharmaTech Inc.s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Quest PharmaTech Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Quest PharmaTech Inc. s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Quest PharmaTech Inc.

and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Quest PharmaTech Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Quest PharmaTech Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues

Browse Complete Report with TOC @

To Get Sample Copy of Report visit @

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Quest PharmaTech Inc. Snapshot 5

Quest PharmaTech Inc. Overview 5

Key Information 5

Key Facts 5

Quest PharmaTech Inc. - Research and Development Overview 6

Key Therapeutic Areas 6

Quest PharmaTech Inc. - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Pipeline Products - Partnered Products 10

Partnered Products/Combination Treatment Modalities 11

Quest PharmaTech Inc. - Pipeline Products Glance 12

Quest PharmaTech Inc. - Clinical Stage Pipeline Products 12

Phase II Products/Combination Treatment Modalities 12

Phase I Products/Combination Treatment Modalities 13

Quest PharmaTech Inc. - Early Stage Pipeline Products 14

Preclinical Products/Combination Treatment Modalities 14

Quest PharmaTech Inc. - Drug Profiles 15

oregovomab 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

SL-052 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

AR-20.5 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Monoclonal Antibody To Target MUC1 for Oncology 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Monoclonal Antibody to Antagonize HER2/neu for Breast Cancer 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Monoclonal Antibody to Inhibit PSA for Prostate Cancer 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Quest PharmaTech Inc. - Pipeline Analysis 24

Quest PharmaTech Inc. - Pipeline Products by Target 24

Quest PharmaTech Inc. - Pipeline Products by Route of Administration 25

Quest PharmaTech Inc. - Pipeline Products by Molecule Type 26

Quest PharmaTech Inc. - Pipeline Products by Mechanism of Action 27

Quest PharmaTech Inc. - Recent Pipeline Updates 28

Quest PharmaTech Inc. - Discontinued Pipeline Products 30

Discontinued Pipeline Product Profiles 30

ACP-2127 30

oregovomab 30

Quest PharmaTech Inc. - Locations And Subsidiaries 31

Head Office 31

Appendix 32

Methodology 32

Coverage 32

Secondary Research 32

Primary Research 32

Expert Panel Validation 32

Contact Us 32

Disclaimer 33

Read More

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.

iData Insights

Tel: 1-866-237-2965


AboutiData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects